Avanos Medical, Inc. (AVNS) is a publicly traded Healthcare sector company. As of May 21, 2026, AVNS trades at $24.74 with a market cap of $1.16B and a P/E ratio of -2.90. AVNS moved -0.04% today. Year to date, AVNS is +118.74%; over the trailing twelve months it is +88.86%. Its 52-week range spans $9.30 to $24.91. Rallies surfaces AVNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded AVNS stock?
Rallies tracks politician and congressional stock disclosures for AVNS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Holbrook Kerr sold 13.83K (~$152.17K) on Nov 18, 2025.
Holbrook Kerr sold 100 (~$1.10K) on Nov 18, 2025.
Holbrook Kerr sold 761 (~$8.38K) on Nov 18, 2025.
AVNS Analyst Consensus
AVNS analyst coverage data. Average price target: $0.00.
Common questions about AVNS
Which politicians traded AVNS stock?
Rallies tracks politician and congressional stock disclosures for AVNS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in AVNS?
Yes. Rallies tracks politician and congressional stock disclosures for AVNS, including reported purchases, sales, dates, owners, and trade amounts when available.
Is AVNS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for AVNS. It does not provide personalized investment advice.
